Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
UBS
Healthtrust
Cerilliant
Queensland Health
Fuji
McKesson
Argus Health
Fish and Richardson

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020784

« Back to Dashboard

NDA 020784 describes NASACORT HFA, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. Additional details are available on the NASACORT HFA profile page.

The generic ingredient in NASACORT HFA is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Eighty-five suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Medical Subject Heading (MeSH) Categories for 020784

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SPRAY, METERED;NASALStrength0.055MG/SPRAY
Approval Date:Apr 7, 2004TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Fish and Richardson
Cantor Fitzgerald
Merck
Moodys
Harvard Business School
Boehringer Ingelheim
Julphar
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot